1. Home
  2. OMF vs BLCO Comparison

OMF vs BLCO Comparison

Compare OMF & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OMF
  • BLCO
  • Stock Information
  • Founded
  • OMF 1920
  • BLCO 1853
  • Country
  • OMF United States
  • BLCO Canada
  • Employees
  • OMF N/A
  • BLCO N/A
  • Industry
  • OMF Finance: Consumer Services
  • BLCO Ophthalmic Goods
  • Sector
  • OMF Finance
  • BLCO Health Care
  • Exchange
  • OMF Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • OMF 6.7B
  • BLCO 7.0B
  • IPO Year
  • OMF 2013
  • BLCO 2022
  • Fundamental
  • Price
  • OMF $54.36
  • BLCO $18.72
  • Analyst Decision
  • OMF Buy
  • BLCO Buy
  • Analyst Count
  • OMF 15
  • BLCO 12
  • Target Price
  • OMF $55.57
  • BLCO $20.91
  • AVG Volume (30 Days)
  • OMF 769.9K
  • BLCO 488.4K
  • Earning Date
  • OMF 02-05-2025
  • BLCO 10-30-2024
  • Dividend Yield
  • OMF 7.71%
  • BLCO N/A
  • EPS Growth
  • OMF N/A
  • BLCO N/A
  • EPS
  • OMF 4.56
  • BLCO N/A
  • Revenue
  • OMF $2,491,000,000.00
  • BLCO $4,684,000,000.00
  • Revenue This Year
  • OMF N/A
  • BLCO $17.39
  • Revenue Next Year
  • OMF $11.30
  • BLCO $6.18
  • P/E Ratio
  • OMF $11.82
  • BLCO N/A
  • Revenue Growth
  • OMF N/A
  • BLCO 18.01
  • 52 Week Low
  • OMF $41.70
  • BLCO $13.16
  • 52 Week High
  • OMF $57.97
  • BLCO $21.69
  • Technical
  • Relative Strength Index (RSI)
  • OMF 46.70
  • BLCO 42.05
  • Support Level
  • OMF $53.70
  • BLCO $18.41
  • Resistance Level
  • OMF $56.49
  • BLCO $18.89
  • Average True Range (ATR)
  • OMF 0.97
  • BLCO 0.48
  • MACD
  • OMF -0.55
  • BLCO -0.12
  • Stochastic Oscillator
  • OMF 15.63
  • BLCO 33.67

About OMF OneMain Holdings Inc.

OneMain Holdings Inc is engaged in nonprime consumer finance companies in the United States and is one of only a few companies in the consumer installment lending industry. It formed after a transaction brought together two branch-based consumer finance companies with complementary strategies and locations. Its services include providing personal loan products, offering credit and noncredit insurance, servicing loans, pursuing strategic acquisitions and dispositions of assets and businesses, and on occasion, establishing joint ventures or forming strategic alliances. The company's one reportable segment is consumer and insurance. In addition to hundreds of branches, the company also has an online business. The main source of revenue is net interest income.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: